Empirical metallicity-dependent calibrations of effective temperature against colours for dwarfs and giants based on interferometric data

We present empirical metallicity-dependent calibrations of effective temperature against colours for dwarfs of luminosity classes IV and V and for giants of luminosity classes II and III, based on a collection from the literature of about two hundred nearby stars with direct effective temperature measurements of better than 2.5 per cent. The calibrations are valid for an effective temperature range 3,100 - 10,000 K for dwarfs of spectral types M5 to A0 and 3,100 - 5,700 K for giants of spectral types K5 to G5. A total of twenty-one colours for dwarfs and eighteen colours for giants of bands of four photometric systems, i.e. the Johnson ($UBVR_{\rm J}I_{\rm J}JHK$), the Cousins ($R_{\rm C}I_{\rm C}$), the Sloan Digital Sky Survey (SDSS, $gr$) and the Two Micron All Sky Survey (2MASS, $JHK_{\rm s}$), have been calibrated. Restricted by the metallicity range of the current sample, the calibrations are mainly applicable for disk stars ([Fe/H]$\,\gtrsim\,-1.0$). The normalized percentage residuals of the calibrations are typically 2.0 and 1.5 per cent for dwarfs and giants, respectively. Some systematic discrepancies at various levels are found between the current scales and those available in the literature (e.g. those based on the infrared flux method IRFM or spectroscopy). Based on the current calibrations, we have re-determined the colours of the Sun. We have also investigated the systematic errors in effective temperatures yielded by the current on-going large scale low- to intermediate-resolution stellar spectroscopic surveys. We show that the calibration of colour ($g-K_{\rm s}$) presented in the current work provides an invaluable tool for the estimation of stellar effective temperature for those on-going or upcoming surveys.Comment: 28 pages, 19 figures, 8 tables, accepted for publication in MNRA

Galactic Disk Bulk Motions as Revealed by the LSS-GAC DR2

We report a detailed investigation of the bulk motions of the nearby Galactic stellar disk, based on three samples selected from the LSS-GAC DR2: a global sample containing 0.57 million FGK dwarfs out to $\sim$ 2 kpc, a local subset of the global sample consisting $\sim$ 5,400 stars within 150 pc, and an anti-center sample containing $\sim$ 4,400 AFGK dwarfs and red clump stars within windows of a few degree wide centered on the Galactic anti-center. The global sample is used to construct a three-dimensional map of bulk motions of the Galactic disk from the solar vicinity out to $\sim$ 2 kpc with a spatial resolution of $\sim$ 250 pc. Typical values of the radial and vertical components of bulk motion range from $-$15 km s$^{-1}$ to 15 km s$^{-1}$, while the lag behind the circular speed dominates the azimuthal component by up to $\sim$ 15 km s$^{-1}$. The map reveals spatially coherent, kpc-scale stellar flows in the disk, with typical velocities of a few tens km s$^{-1}$. Bending- and breathing-mode perturbations are clearly visible, and vary smoothly across the disk plane. Our data also reveal higher-order perturbations, such as breaks and ripples, in the profiles of vertical motion versus height. From the local sample, we find that stars of different populations exhibit very different patterns of bulk motion. Finally, the anti-center sample reveals a number of peaks in stellar number density in the line-of-sight velocity versus distance distribution, with the nearer ones apparently related to the known moving groups. The "velocity bifurcation" reported by Liu et al. (2012) at Galactocentric radii 10--11 kpc is confirmed. However, just beyond this distance, our data also reveal a new triple-peaked structure.Comment: 27 pages, 17 figures, Accepted for publication in a special issue of Research in Astronomy and Astrophysics on LAMOST science

Electrocatalysis of Oxygen Reduction on Te-Modified Platinum Stepped Crystal Surfaces

Te-modified platinum single-crystal surfaces in the [011̅] zone have been used as model electrocatalysts for oxygen reduction reaction (ORR). The results clearly show that (1) except for Pt(111), all other electrodes display enhanced ORR activity when Te is deposited on the surface; (2) the intrinsic ORR activity for Pt(hkl) decreases in the order of Pt(322) > Pt(755) > Pt(977) > Pt(111) > Pt(311) > Pt(100), while the enhancement factor for ORR with Te modification decreases in the order of Pt(100) > Pt(311) > Pt(977) > Pt(755) > Pt(322); (3) metallic Te and its charge transfer to Pt as well as the consequent lower d-band center and OHad binding energy are probably the reasons for the enhanced electrocatalysis for ORR with Te modification; and (4) the inhibition of Te at Pt(111) as well as the smaller extent for the enhancement of Te at Pt(S)-[n(111) × (100)] with longer terraces in the kinetic region for ORR are a result of partial oxidation of Te. The weaker electronic interaction of Te with the Pt substrate is probably the origin of its facile oxidation at lower potential. Our results imply that modification of Pt with species that can transfer electrons to Pt may be an efficient strategy to enhance the ORR activity.This work was supported by the National Natural Science Foundation of China (No. 22172151, 21972131, and 21832004). E.H. gratefully acknowledged the International Professorship by USTC and financial support from the Ministerio de Ciencia e Innovación (project PID2022–137350NB-I00)

Immunologic Changes during Pandemic (H1N1) 2009, China

We analyzed changes in immunologic values over time for 28 hospitalized patients with pandemic (H1N1) 2009. Levels of interleukin-6, interferon-γ, and interleukin-10 increased 1 day after illness onset and then decreased to baseline levels. Levels of virus-specific antibody were undetectable 1 day after illness onset and peaked 36 days later

Systemically administered liposome-encapsulated Ad-PEDF potentiates the anti-cancer effects in mouse lung metastasis melanoma

BACKGROUND: The use of adenoviral vector for gene therapy is still an important strategy for advanced cancers, however, the lack of the requisite coxsackie-adenovirus receptor in cancer cells and host immune response to adenovirus limit the application of adenoviral vector in vivo. METHOD: We designed the antiangiogenic gene therapy with recombinant PEDF adenovirus (Ad-PEDF) encapsulated in cationic liposome (Ad-PEDF/Liposome), and investigated the anti-tumor efficacy of Ad-PEDF/Liposome complex on inhibition of tumor metastasis. RESULTS: We found that systemic administration of Ad-PEDF/liposome was well tolerated and resulted in marked suppression of tumor growth, and was more potent than uncoated Ad-PEDF to induce apoptosis in B16-F10 melanoma cells and inhibit murine pulmonary metastases in vivo. After Ad-luciferase was encapsulated with liposome, its distribution decreased in liver and increased in lung. The anti-Ad IgG level of Ad-PEDF/Liposome was significantly lower than Ad-PEDF used alone. CONCLUSION: The present findings provide evidences of systematic administration of cationic liposome-encapsulated Ad-PEDF in pulmonary metastatic melanoma mice model, and show an encouraging therapeutic effect for further exploration and application of more complexes based on liposome-encapsulated adenovirus for more cancers

MODIFIED YUPINGFENG FORMULA FOR THE TREATMENT OF STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS

Background: Chronic obstructive pulmonary disease (COPD), is a very common disease of respiratory system. An increasing number of clinical trials on Yupingfeng formula in the management of stable COPD have been performed. However, the evidence base for it remains unknown. This review aims at assessing the efficacy, and safety of modified Yupingfeng formula in the treatment of stable COPD through a systematic review of all available randomized controlled trials. Materials and Methods: Literature retrieval was conducted using four English databases (CENTRAL, PubMed, EMBASE, and ISI Web of Science), and four Chinese databases (CBM, CNKI, VIP, and WANFANG), from respective inception to January 2013, and supplemented with a manual search. Review authors independently extracted the trial data, and assessed the quality of each trial. Methodological quality was assessed by Cochrane risk of bias and Jadad’s scale. The following outcomes were evaluated: (1) lung function; (2) 6-minute walk distance (6MWD); (3) effective rate; (4) serum levels of IgA, IgG and IgE; and (5) adverse events. Data were analyzed using STATA 12.0 software. Results: A total of nine studies involving 660, stable COPD patients were identified. Patients from all studies included in this review were randomized to receive Yupingfeng formula combined with Western medications in comparison with Western medications. In general, the methodological quality of the included trials was poor. The results of this systematic review indicates that, compared with Western medications alone, the use of Yupingfeng formula, if combined with Western medications could significantly improve FEV1 (WMD = 0.30L; 95%CI: 0.19, 0.42), FEV1/FVC ratio (SMD = 0.69; 95%CI: 0.48, 0.91), 6MWD (WMD = 31.73m; 95% CI: 19.29, 44.17), and effective rate (RR = 1.24; 95% CI: 1.10, 1.41), and increase the serum levels of IgA (WMD = 0.25; 95%CI: 0.16, 0.34) and IgG (WMD = 1.10; 95%CI: 0.53, 1.68), but no difference was found in the serum IgE levels (WMD = 0.47; 95%CI: -0.32, 1.27) between the two groups. No serious adverse events were reported. Conclusions: Within the limitations of this systematic review, we may conclude that compared with Western medications alone, Yupingfeng formula, when combined with Western medications can provide more benefits for patients with stable COPD, without any serious adverse reactions being identified. However, these benefits need to be further confirmed through high-quality prospective placebo-controlled trials that should be strictly conducted in accordance with methodological principles and procedures